Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.
Alhalabi O, Hahn AW, Msaouel P, Meric-Bernstam F, Wilson N, Naing A, Piha-Paul S, Janku F, Pant S, Yap TA, Hong DS, Fu S, Karp D, Beltran K, Campbell E, Le H, Campbell MT, Shah A, Tannir NM, Siefker-Radtke A, Gao J, Roszik J, Subbiah V.
Alhalabi O, et al. Among authors: shah a.
Clin Genitourin Cancer. 2022 Feb;20(1):e16-e24. doi: 10.1016/j.clgc.2021.07.004. Epub 2021 Jul 12.
Clin Genitourin Cancer. 2022.
PMID: 34362693